KM
Kenneth H. Mayer
Highly rated in
11
conditions
Highly rated in
11
conditions
Check Dr. Kenneth H. Mayer's experience treating your condition:
About Dr. Kenneth H. Mayer

Kenneth Mayer is an Infectious Disease expert in Providence, Rhode Island. Mayer has been practicing medicine for over 45 years and is highly rated in 11 conditions, according to our data. His top areas of expertise are HIV/AIDS, Syphilis, Gonorrhea, Adult T-Cell Leukemia, and Tissue Biopsy. He is licensed to treat patients in Massachusetts and Rhode Island. Mayer is currently accepting new patients.

His clinical research consists of co-authoring 961 peer reviewed articles and participating in 17 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Kenneth H. Mayer it is best to call his office and ask if your insurance is accepted.


Dr. Kenneth H. Mayer accepts the following insurance:

  •  Ambetter
  •  Anthem
Locations
164 Summit Ave, Providence, RI 02906
Background & Education
Graduate Institution
Northwestern University Medical School, 1977
Specialties
Infectious Disease
Licenses
Internal Medicine in MA
Languages Spoken
English
Spanish
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


15 Clinical Trials

Making it Last: A Randomized, Controlled Trial of a Home Care System to Promote Persistence in PrEP Care
Evaluation of Life-Steps to Enhance Adherence and Engagement in PrEP Care
A Phase IV Open-label Evaluation of Safety, Tolerability and Acceptability of Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Disoproxil Fumarate Single-tablet Regimen for Non-occupational Prophylaxis Following Potential Exposure to HIV-1
TechStep: Technology-based Stepped Care to Stem Transgender Adolescent Risk Transmission
A Phase IV Open-Label Evaluation of Safety, Tolerability and Patient Acceptance of Raltegravir (MK-0518) Combined With a Fixed-Dose Formulation of Tenofovir Following Potential Exposure to HIV-1
Gender-Affirmative Medical Care to Improve HIV Treatment Cascade Among Transgender Women
Comparison of Men's Prevention Apps to Research Efficacy
Enhancing HIV Prevention Among HIV Infected Men
A Phase IV Open-label Evaluation of Safety, Tolerability and Patient Acceptance of Atazanavir Boosted With Ritonavir Combined With a Fixed-dose Formulation of Tenofovir DF and Emtricitabine for Non-occupational Prophylaxis Following Potential Exposure to HIV-1
Feasibility of Short-Term PrEP Uptake for MSM With Episodic High-Risk for HIV
Phase II Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative Men
A Phase IV Open-label Evaluation of Safety, Tolerability, and Acceptability of a Fixed-dose Formulation of Bictegravir, Emtricitabine/Tenofovir Alafenamide (B/F/TAF) for Non-occupational Prophylaxis Following Potential Exposure to HIV-1
View 12 Less Clinical Trials -

961 Total Publications

Characterizing Arrest and Incarceration in a Prospective Cohort of Transgender Women.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors